MENU
+Compare
TEVA
Stock ticker: NYSE
AS OF
Jul 25 closing price
Price
$16.54
Change
+$0.21 (+1.29%)
Capitalization
15.06B

TEVA Teva Pharmaceutical Industries Limited Forecast, Technical & Fundamental Analysis

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world... Show more

TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TEVA with price predictions
Jul 25, 2025

TEVA in upward trend: price may ascend as a result of having broken its lower Bollinger Band on July 15, 2025

TEVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 43 cases where TEVA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 25, 2025. You may want to consider a long position or call options on TEVA as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TEVA just turned positive on July 24, 2025. Looking at past instances where TEVA's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

TEVA moved below its 50-day moving average on July 07, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for TEVA crossed bearishly below the 50-day moving average on July 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TEVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for TEVA entered a downward trend on July 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. TEVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TEVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.077) is normal, around the industry mean (62.701). P/E Ratio (22.624) is within average values for comparable stocks, (88.783). Projected Growth (PEG Ratio) (1.594) is also within normal values, averaging (2.913). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.982) is also within normal values, averaging (18.372).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TEVA is expected to report earnings to rise 21.15% to 62 cents per share on July 30

Teva Pharmaceutical Industries Limited TEVA Stock Earnings Reports
Q2'25
Est.
$0.63
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.06
The last earnings report on May 07 showed earnings per share of 51 cents, beating the estimate of 47 cents. With 9.21M shares outstanding, the current market capitalization sits at 15.06B.
A.I.Advisor
published Dividends

TEVA paid dividends on December 12, 2017

Teva Pharmaceutical Industries Limited TEVA Stock Dividends
А dividend of $0.09 per share was paid with a record date of December 12, 2017, and an ex-dividend date of November 27, 2017. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
124 Dvora HaNevi’a Street
Phone
+972 39148213
Employees
37851
Web
https://www.tevapharm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IWFG52.870.26
+0.50%
NYLI Winslow Focused Large Cap Gr ETF
SOR43.830.07
+0.15%
Source Capital
PSQO20.580.01
+0.05%
Palmer Square Credit Opportunities ETF
GGT4.27-0.01
-0.23%
THE Gabelli Multimedia Trust
SIL50.05-0.39
-0.77%
Global X Silver Miners ETF

TEVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TEVA has been loosely correlated with AMRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TEVA jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
+1.29%
AMRX - TEVA
38%
Loosely correlated
+0.75%
ELAN - TEVA
31%
Poorly correlated
+1.57%
VTRS - TEVA
30%
Poorly correlated
+0.64%
CGC - TEVA
26%
Poorly correlated
+2.70%
BHC - TEVA
26%
Poorly correlated
N/A
More